Contact
Please use this form to send email to PR contact of this press release:
Medigene, IRICoR and Université de Montréal Sign Collaboration and Exclusive Licensing Option on Novel Cancer Antigens
TO:
Please use this form to send email to PR contact of this press release:
Medigene, IRICoR and Université de Montréal Sign Collaboration and Exclusive Licensing Option on Novel Cancer Antigens
TO: